Cargando…

Ticagrelor after Acute Coronary Syndrome: One For All or Part of Personalized Medicine?

Detalles Bibliográficos
Autores principales:	Akin, Ibrahim, Nienaber, Christoph A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802043/ https://www.ncbi.nlm.nih.gov/pubmed/35146475 http://dx.doi.org/10.1016/j.lanepe.2022.100309

Ejemplares similares

Metabolism of ticagrelor in patients with acute coronary syndromes
por: Adamski, Piotr, et al.
Publicado: (2018)

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
por: Birkeland, Kade, et al.
Publicado: (2010)

Critical appraisal of ticagrelor in the management of acute coronary syndrome
por: Nawarskas, James J, et al.
Publicado: (2011)

Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome
por: Souza Teixeira, Edenilson de, et al.
Publicado: (2023)

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor
por: Parodi, Guido, et al.
Publicado: (2015)

Digital twins to personalize medicine
por: Björnsson, Bergthor, et al.
Publicado: (2019)

Variable Brugada syndrome phenotype severity in a dish: dreams meet reality
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

T-lymphoid progenitor-based immunotherapies: clinical perspectives for one and all
por: Gaudeaux, P., et al.
Publicado: (2022)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome
por: Ozaki, Aya F., et al.
Publicado: (2022)

Effect of altitude on ticagrelor-induced dyspnea in patients with acute coronary syndrome
por: Kocabay, Gonenc, et al.
Publicado: (2023)

The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: early invasive strategy for all?
por: Arslan, F., et al.
Publicado: (2017)

Prognostic value of mean platelet volume in patients after acute coronary syndrome
por: Jakl, Martin, et al.
Publicado: (2015)

Algorithmic fairness audits in intensive care medicine: artificial intelligence for all?
por: van de Sande, Davy, et al.
Publicado: (2022)

Will future microbots be task-specific customized machines or multi-purpose “all in one” vehicles?
por: Wang, Joseph
Publicado: (2021)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand
por: Yamwong, Sukit, et al.
Publicado: (2014)

Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome
por: Zou, Yuting, et al.
Publicado: (2022)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
por: LU, YANJIAO, et al.
Publicado: (2016)

A Different Way of Coronary Lesion Preparation: Stentablation and Rotastenting
por: Akin, Ibrahim, et al.
Publicado: (2012)

Management of infants with congenital diaphragmatic hernia and pulmonary hypertension—one size does not fit all
por: Greenough, Anne
Publicado: (2023)

Successful Caesarean Section on Ticagrelor Treatment One Day after Primary Percutaneous Coronary Intervention
por: Antonijevic, Nebojsa, et al.
Publicado: (2023)

Comparison of Ticagrelor Monotherapy and Ticagrelor Plus Aspirin Among Patients With Acute Coronary Syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Tian, Ming-Yu, et al.
Publicado: (2023)

Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries
por: Mehtar, Shaheen, et al.
Publicado: (2020)

A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor
por: Labouesse, Marie A., et al.
Publicado: (2021)

Ticagrelor monotherapy after CABG—Probably not at all and definitely not forever
por: Sandner, Sigrid, et al.
Publicado: (2022)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Ticagrelor-induced Diarrhea in a Patient with Acute Coronary Syndrome Requiring Percutaneous Coronary Artery Intervention
por: Alomari, Mohammad, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome: Erratum
Publicado: (2018)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
por: Wang, Dong, et al.
Publicado: (2018)

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
por: ALGÜL, Engin, et al.
Publicado: (2019)

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
por: He, Peixun, et al.
Publicado: (2021)

Combined glycoprotein IIb/IIIa inhibitor therapy with ticagrelor for patients with acute coronary syndrome
por: Xie, Zhi-Jiang, et al.
Publicado: (2021)

Influence of body size on platelet response to ticagrelor and prasugrel in patients with acute coronary syndromes
por: Ndrepepa, Gjin, et al.
Publicado: (2021)

Ticagrelor Versus Clopidogrel in East Asian Patients With Acute Coronary Syndrome and Diabetes Mellitus
por: Choi, Yeonwoo, et al.
Publicado: (2022)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis
por: Chenna, Venkata Sai Harshabhargav, et al.
Publicado: (2023)

Measuring hospital performance in the management of acute coronary syndromes
por: de Winter, R. J.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a0ah8sjhrgekt1v9qn4ujbdoe3